Literature DB >> 15299950

X-ray structure of the 154-amino-acid form of recombinant human basic fibroblast growth factor. comparison with the truncated 146-amino-acid form.

J S Kastrup1, E S Eriksson, H Dalbøge, H Flodgaard.   

Abstract

The crystal structure of the 154-amino-acid form of human basic fibroblast growth factor (hbFGF154), probably representing the intact form of hbFGF as deduced from the open reading frame of hbFGF cDNA, was determined by X-ray crystallography and refined to a crystallographic residual of 19.0% for all data between 20.0 and 2.0 A resolution. Crystals were obtained from recombinant hbFGF154 expressed in E. coli. hbFGF154 has the same overall structure as the N-terminus truncated 146-amino-acid form. The structure has a Kunitz-type fold and is built of 12 beta-strands of which six antiparallel strands form a beta-sheet barrel. In the structure it was possible to locate two additional residues at the N terminus and the last three C-terminal amino-acid residues, which seem to be disordered in all but one of the reported structures of the truncated form of hbFGF. The C-terminal amino-acid residues are part of the last beta-strand through the formation of a hydrogen bond between the main-chain amide group of Ala152 and the carbonyl O atom of Pro28. An apparent phosphate ion is bound within the basic region on the surface of the molecule and has as ligands the side chains of Asn35, Arg128 and Lys133 and two water molecules. A slightly different hydrogen-bonding pattern to the phosphate ion is observed as compared with the sulfate ions in the truncated forms [Eriksson, Cousens & Matthews (1993). Protein Sci. 2, 1274-1284; Zhang, Cousens, Barr & Sprang (1991). Proc. Natl Acad. Sci. USA, 88, 3446-3450]. One molecule of beta-mercaptoethanol forms a disulfide bridge to Cys77.

Entities:  

Year:  1997        PMID: 15299950     DOI: 10.1107/S0907444996012711

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  7 in total

1.  LMProt: an efficient algorithm for Monte Carlo sampling of protein conformational space.

Authors:  Roosevelt Alves da Silva; Léo Degrève; Antonio Caliri
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

2.  Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)-dependent oligomerization of fibroblast growth factor 2 (FGF2) triggers the formation of a lipidic membrane pore implicated in unconventional secretion.

Authors:  Julia P Steringer; Stephanie Bleicken; Helena Andreas; Sonja Zacherl; Mareike Laussmann; Koen Temmerman; F Xabier Contreras; Tanmay A M Bharat; Johannes Lechner; Hans-Michael Müller; John A G Briggs; Ana J García-Sáez; Walter Nickel
Journal:  J Biol Chem       Date:  2012-06-23       Impact factor: 5.157

3.  Cholesterol promotes clustering of PI(4,5)P2 driving unconventional secretion of FGF2.

Authors:  Fabio Lolicato; Roberto Saleppico; Alessandra Griffo; Annalena Meyer; Federica Scollo; Bianca Pokrandt; Hans-Michael Müller; Helge Ewers; Hendrik Hähl; Jean-Baptiste Fleury; Ralf Seemann; Martin Hof; Britta Brügger; Karin Jacobs; Ilpo Vattulainen; Walter Nickel
Journal:  J Cell Biol       Date:  2022-09-29       Impact factor: 8.077

4.  Key steps in unconventional secretion of fibroblast growth factor 2 reconstituted with purified components.

Authors:  Julia P Steringer; Sascha Lange; Sabína Čujová; Radek Šachl; Chetan Poojari; Fabio Lolicato; Oliver Beutel; Hans-Michael Müller; Sebastian Unger; Ünal Coskun; Alf Honigmann; Ilpo Vattulainen; Martin Hof; Christian Freund; Walter Nickel
Journal:  Elife       Date:  2017-07-19       Impact factor: 8.140

5.  The Na,K-ATPase acts upstream of phosphoinositide PI(4,5)P2 facilitating unconventional secretion of Fibroblast Growth Factor 2.

Authors:  Cyril Legrand; Roberto Saleppico; Jana Sticht; Fabio Lolicato; Hans-Michael Müller; Sabine Wegehingel; Eleni Dimou; Julia P Steringer; Helge Ewers; Ilpo Vattulainen; Christian Freund; Walter Nickel
Journal:  Commun Biol       Date:  2020-03-25

6.  Detection of ATP-binding to growth factors.

Authors:  Simone König; Anja Hasche; Stefanie Pallast; Josef Krieglstein; Susanne Klumpp
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-30       Impact factor: 3.109

Review 7.  Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.

Authors:  Aleksandar Bijelic; Manuel Aureliano; Annette Rompel
Journal:  Angew Chem Int Ed Engl       Date:  2018-10-12       Impact factor: 15.336

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.